InnoStar
Pharmaceutical Manufacturing • 
1360 Valley Vista Dr, Diamond Bar, United States • 21-50 Employees
Company overview
| Headquarters | 1360 Valley Vista Dr, Diamond Bar, California 91765, US |
| Phone number | +862160211999 |
| Website | |
| NAICS | 3254 |
| Keywords | CRO, Pharmacokinetics, Drug Discovery, Small Molecules, Radiopharmaceutical, Disease Models, Animal Models, Peptide Drugs, ADC, Bioanalysis, Drug Screening, Pharmacodynamics, Therapeutic Vaccines, Protac, Safety Evaluation, New Drug R&D, Molecular Glues, Antibody Drugs, Cell And Gene Therapeutics, Druggability Assessment, New Drug Registration, Nonclinical Assessment, Prophylactic Vaccine, Monkey Study, Toxicology Study, Biomarker Study, Nonhuman Primates |
| Founded | 2010 |
| Employees | 21-50 |
Key Contacts at InnoStar
Haixia Zhang
Director Of Business Development
Eleanor Li
Pmo Director
Jason Zhan
Project Management Director
Amanda Meng
Bd Director
InnoStar Email Formats
InnoStar uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@innostar.cn), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@innostar.cn | 100% |
About InnoStar
Founded in 2010, InnoStar has successfully supported global pharmaceutical and biotech companies with drug discovery, ADME, PK/PD, toxicology, biomarkers, and bioanalysis services. With state-of-the-art facilities across China and the U.S. and a team of over 1,000 scientists, we have enabled hundreds of IND and NDA/BLA approvals worldwide. InnoStar is GLP-certified by multiple international authorities, including the U.S. FDA, NMPA, and OECD, ensuring compliance with global regulatory standards. Our mission is to accelerate innovative drug development and support our clients in bringing life-saving therapies to patients worldwide. Service experience We have completed over 13,700 projects for more than 770 sponsors. These studies have been submitted in support of over 370 INDs and 18 NDAs/BLAs for innovative drugs in China and 2 NDAs/BLAs in the United States, over 90 INDs in the United States, the European Union, South Korea, and Australia, etc. Data updated to: Dec 31, 2023. InnoStar is committed to providing one-stop service solutions to our sponsors in China and abroad. We are striving to be the scientific and technological innovation pioneer, new drug R&D accelerator, and human life and health guardian. InnoStar was listed on the STAR Market of Shanghai Stock Exchange on September 3, 2024 (Stock code: 688710).
InnoStar revenue & valuation
| Annual revenue | $2,053,320 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $6,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
InnoStar has 7 employees across 3 departments.
Departments
Number of employees
Funding Data
InnoStar has never raised funding before.
InnoStar Tech Stack
Discover the technologies and tools that power InnoStar's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
JavaScript libraries
Programming languages
JavaScript libraries
UI frameworks
JavaScript graphics
Brazil
Hong Kong
United Kingdom
Belgium
Saudi Arabia
Frequently asked questions
4.8
40,000 users
